Lymphoma Clinical Trials in Baltimore

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
I
An Open-Label Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma (CITADEL-203)
Active, not recruiting
  • Lymphoma
  • Phoenix, Arizona
  • +82 more
2021-12-01
Dec 1, 2021
J
A Study of PCI-32765 (Ibrutinib) in Combination With Either Bendamustine and Rituximab or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Participants With Previously Treated Indolent Non-Hodgkin Lymphoma
Active, not recruiting
  • Lymphoma
  • Gilbert, Arizona
  • +134 more
2021-12-02
Dec 2, 2021
N
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1383 more
2021-12-01
Dec 1, 2021
H
A Study of Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab Plus Bendamustine in Participants With Relapsed or Refractory Follicular or Diffuse Large B-Cell Lymphoma - 2021
Completed
  • Lymphoma
  • Birmingham, Alabama
  • +61 more
2021-11-30
Nov 30, 2021
N
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Active, not recruiting
  • Glioma
  • +49 more
  • Duarte, California
  • +11 more
2021-11-30
Nov 30, 2021
N
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
Recruiting
  • Lymphoma
  • +6 more
  • Cytology Specimen Collection Procedure
  • Birmingham, Alabama
  • +139 more
2021-11-27
Nov 27, 2021
I
A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Active, not recruiting
  • Lymphoma
  • Scottsdale, Arizona
  • +20 more
2021-11-12
Nov 12, 2021
B
A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase - 2021
Completed
  • Lymphoma
  • Acute Lymphoblastic Leukemia
  • Apixaban
  • No systemic anticoagulant prophylaxis
  • Phoenix, Arizona
  • +95 more
2021-11-01
Nov 1, 2021
R
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Active, not recruiting
Has Results
  • Chemotherapeutic Agent Toxicity
  • +4 more
  • Rituximab
  • +5 more
  • Birmingham, Alabama
  • +44 more
2021-11-02
Nov 2, 2021
M
TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)
Active, not recruiting
  • Acute Leukemia
  • +3 more
  • Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate
  • +5 more
  • Birmingham, Alabama
  • +38 more
2021-10-25
Oct 25, 2021
M
Rituximab Followed by Combination Chemotherapy in Treating Patients With Refractory or Recurrent Non-Hodgkin's Lymphoma
Withdrawn
  • Lymphoma
  • rituximab
  • +7 more
  • Washington, District of Columbia
  • +1 more
2021-10-19
Oct 19, 2021
H
A Study to Evaluate the Safety and Efficacy of Glofitamab in Combination With Rituximab (R) Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Circulating Tumor (ct)DNA High-Risk Patients With Untreated Diffuse Large B-Cell Lymphoma
Not yet recruiting
  • Lymphoma
  • Duarte, California
  • +21 more
2021-10-22
Oct 22, 2021
C
Study of ACTR707 in Combination With Rituximab in Subjects With Relapsed or Refractory B Cell Lymphoma - 2020
Terminated
  • Lymphoma
  • ACTR707
  • rituximab
  • Gilbert, Arizona
  • +10 more
2021-10-04
Oct 4, 2021
S
S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma
Active, not recruiting
Has Results
  • Lymphoma
  • rituximab
  • +5 more
  • Anchorage, Alaska
  • +258 more
2021-09-21
Sep 21, 2021
R
Study of Cemiplimab and REGN1979 in Patients With Lymphoma
Active, not recruiting
  • Lymphoma
  • Santa Monica, California
  • +21 more
2021-09-20
Sep 20, 2021
C
Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas
Active, not recruiting
  • Anaplastic Large Cell Lymphoma
  • +4 more
  • Laboratory Biomarker Analysis
  • Questionnaire Administration
  • Birmingham, Alabama
  • +106 more
2021-09-02
Sep 2, 2021
C
Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant
Recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • +3 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +3 more
  • Birmingham, Alabama
  • +42 more
2021-08-23
Aug 23, 2021
A
Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma
Active, not recruiting
  • Lymphoma
  • Anchorage, Alaska
  • +125 more
2021-08-16
Aug 16, 2021
G
Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma
Unknown status
  • Lymphoma
  • immunoscintigraphy
  • technetium Tc 99m epratuzumab
  • Los Angeles, California
  • +7 more
2021-08-12
Aug 12, 2021
G
Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma
Unknown status
  • Lymphoma
  • immunoscintigraphy
  • technetium Tc 99m epratuzumab
  • Los Angeles, California
  • +7 more
2021-08-12
Aug 12, 2021
A
Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma - 2018
Completed
Has Results
  • Lymphoma
  • Bleomycin Sulfate
  • +11 more
  • Tucson, Arizona
  • +94 more
2021-06-10
Jun 10, 2021
I
A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6
Recruiting
  • Breast Cancer
  • +10 more
  • Los Angeles, California
  • +7 more
2021-05-10
May 10, 2021
I
A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202) - 2021
Completed
Has Results
  • Lymphoma
  • Birmingham, Alabama
  • +69 more
2021-04-05
Apr 5, 2021
A
Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas
Recruiting
  • Solid Tumors
  • Lymphoma
  • Birmingham, Alabama
  • +69 more
2021-03-29
Mar 29, 2021
S
Observational Trial of Real-World Treatment Utilization and Effectiveness of PI3K-inhibitors in CLL/SLL and FL - 2020
Terminated
  • Lymphoma, Small Lymphocytic
  • +4 more
  • Little Rock, Arkansas
  • +10 more
2021-03-15
Mar 15, 2021